@Ressy the 2 boys in the P2a that saw no effect from the drug were older heavier boys whose muscles were too far gone for the low 25mg dose to have any effect on them.
So the P2a has given some valuable insights into the screening process for the P2b.
And I agree with @itsagas on the scientific expertise that has joined the company is a key sign for me. However you did leave out the AEF also took $1.5m in the placement. Another big tick.
@Ressy the 2 boys in the P2a that saw no effect from the drug...
-
- There are more pages in this discussion • 1,042 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
-0.004(4.55%) |
Mkt cap ! $75.73M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 8.9¢ | 8.4¢ | $69.96K | 815.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 162449 | 8.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.7¢ | 119843 | 1 |
View Market Depth
| Last trade - 15.51pm 18/06/2024 (20 minute delay) ? |
| PER (ASX) Chart |